ストックスクリーナーアプリを入手
3.28
6.02%
-0.21
Aclaris Therapeutics Inc (ACRS) 最新ニュース
Aclaris Therapeutics, Inc. (ACRS) options chain - Yahoo Finance UK
MCPMF Stock Price and Chart — OTC:MCPMF - TradingView
Cantor Fitzgerald reiterates Aclaris Therapeutics stock rating - Investing.com
Cantor Fitzgerald reiterates Aclaris stock rating on LP opportunity - Investing.com
Aclaris Therapeutics, Inc. (8AT.F) stock price, news, quote and history - Yahoo Finance UK
Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength? - Eastern Progress
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 69.2%: Here's is How to Trade - Eastern Progress
Cantor Fitzgerald reiterates Aclaris Therapeutics stock rating By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Aclaris Therapeutics stock rating - Investing.com
Aclaris (ACRS) Soars 6.0%: Is Further Upside Left in the Stock? - Yahoo Finance
Aclaris at Cantor Fitzgerald conference: pipeline, cash, catalysts By Investing.com - Investing.com South Africa
Aclaris at Cantor Fitzgerald conference: pipeline, cash, catalysts By Investing.com - Investing.com Nigeria
Aclaris at Cantor Fitzgerald conference: pipeline, cash, catalysts - Investing.com
Aclaris at Cantor Fitzgerald conference: pipeline, cash, catalysts - Investing.com India
Aclaris at Cantor Fitzgerald conference: pipeline, cash, catalysts By Investing.com - Investing.com UK
Aclaris CEO to Detail Drug Pipeline at Cantor Conference - MyChesCo
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Investing News Network
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - Yahoo Finance
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - GlobeNewswire
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference - GlobeNewswire
Canaccord initiates Aclaris stock with buy rating on pipeline potential By Investing.com - Investing.com South Africa
Canaccord initiates Aclaris stock with buy rating on pipeline potential By Investing.com - Investing.com Australia
Canaccord initiates Aclaris stock with buy rating on pipeline potential By Investing.com - Investing.com Canada
Canaccord initiates Aclaris stock with buy rating on pipeline potential - Investing.com India
CCORF Initiates Aclaris Therapeutics(ACRS.US) With Buy Rating, Announces Target Price $10 - Moomoo
Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target - Yahoo Finance
Piper Sandler reiterates Aclaris stock rating on asthma data By Investing.com - Investing.com India
Piper Sandler reiterates Aclaris stock rating on asthma data By Investing.com - Investing.com Canada
Piper Sandler reiterates Aclaris stock rating on asthma data By Investing.com - Investing.com Nigeria
Piper Sandler reiterates Aclaris stock rating on asthma data By Investing.com - Investing.com UK
ETFs Investing in Aclaris Therapeutics, Inc. Stocks - TradingView
Aclaris Therapeutics (NASDAQ:ACRS) Stock: What Comes Next? - Kalkine Media
Aclaris Therapeutics (NASDAQ:ACRS) Trading 4.7% HigherWhat's Next? - MarketBeat
Aclaris Therapeutics (ACRS) Edges Lower by 1.37% as Shares Test Key Technical FloorRevenue Growth Stocks - vinanet.vn
Sei Investments Co. Makes New Investment in Aclaris Therapeutics, Inc. $ACRS - MarketBeat
Dimensional Fund Advisors LP Has $1.91 Million Stock Position in Aclaris Therapeutics, Inc. $ACRS - MarketBeat
FDA Fast Track Status Advances Aclaris Lichen Planus Drug - MyChesCo
HC Wainwright Has Pessimistic Outlook of ACRS Q3 Earnings - MarketBeat
Renaissance Technologies LLC Has $1.89 Million Stake in Aclaris Therapeutics, Inc. $ACRS - MarketBeat
Aclaris Therapeutics, Inc. (ACRS) stock price, news, quote and history - Yahoo Finance Australia
Aclaris Raises Capital as Drug Pipeline Spending Accelerates - MyChesCo
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Brokerages - MarketBeat
Aclaris Therapeutics, Inc. (ACRS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 69.2%: Here's is How to Trade - Zacks Investment Research
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 69.2%: Here's is How to Trade - Yahoo Finance
Weekly Recap: Q2 loss, runway into 2028 and Fast Track for modzatinib - TradingView
H.C. Wainwright Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Aclaris Therapeutics (ACRS) Stock Drifts Lower As Losses Deepen On Thin Revenue - simplywall.st
Aclaris Updates At-The-Market Equity Sales Agreement - The Globe and Mail
Aclaris Therapeutics (NASDAQ:ACRS) Stock Price Down 6%Here's What Happened - MarketBeat
4.22%
大文字化:
|
ボリューム (24 時間):